Skip to main content

Research at Alzheimer Society of Canada

1-855-705-4636
  • Find a Research Study
  • FAQs
  • Legal Disclaimer
  • Contact Us
  • Français

Alzheimer Society of Canada

Find a Research Study

The PREVENT Study (Predementia Neuroimaging of Transient Ischemic Attack): A prospective longitudinal cohort study to identify biological and psychological predictors of cognitive decline in transient ischemic attack patients

What is this Study about?

PREVENT is recruiting healthy control participants for a prospective longitudinal cohort study. The aim of the study is to help doctors diagnose dementia sooner using serial magnetic resonance imaging (MRI) and other biomarkers in the blood and cerebrospinal fluid. We hypothesize that individuals who have had a TIA ("ministroke") are more likely to show early signs of dementia through higher rates of brain shrinkage and cognitive decline as compared to healthy individuals over a 5-year period.

All data will be analyzed as a group aggregate and the results of our study will be published in scientific journals. Identifying information will not be included in any publications.

What Will Happen in This Study?

If you agree to participate in this study and you meet all of the criteria, a study doctor will collect information from you and will review your health records by accessing your medical history. You will be given a parking pass and asked to come to the Foothills Hospital at your convenience for a 30 minute MRI and a 1 hour standardized cognitive test. The MRI and cognitive testing will be repeated again at 1, 3 and 5 years. Optionally, you may choose to consent to a one-time blood sample draw and/or lumbar puncture, which will allow us to detect genetic markers or proteins associated with dementia.

Who is Eligible to Participate in this Study?

To be eligible to participate in this study, you must meet the following criteria:

  • You are between the ages of 45-80
  • You do not have history of TIA or stroke
  • You are ambulatory
  • You are English-speaking or have a translator available
  • You are not deaf or hard of hearing
  • You have capacity and competence to provide consent and report symptoms
  • You do not have a contraindication to MR scanning, such as heart pacemaker, metallic foreign body, or aneurysm clip
Get in Touch About this Study

Legal Disclaimer

Any materials or links provided herein are strictly for informational purposes only. The Alzheimer Society of Canada does not endorse nor recommend any of the manufacturers, products or institutions mentioned in any of these links or listings as suitable or appropriate for your particular situation or circumstances and disclaims any liability with respect to representations, warranties, including fitness for an intended particular use or purpose, and all other claims relating thereto, all of which remain strictly with the manufacturer or institution.

In no event shall the Alzheimer Society of Canada or any third parties mentioned on the website be liable for any damage (including, without limitation, incidental and consequential damages for personal injury/wrongful death, lost profits or damages resulting from lost data or business interruption) or personal injury (including death) resulting from the use, misuse or inability to use any activity, product or service mentioned herein, whether based in warranty, contract, tort or any other legal theory.

Everyone considering participating in any activity is encouraged to speak with their own doctor or health-care team before participating in any activity that may impact their health or well-being.

Observational Study

Target Population

Healthy volunteers, Caregivers, Researchers and Healthcare Professionals, Client Service Staff, Family members

Target Age Group(s)

41-65, 66+

Study Location

In-Person

Foothills Hospital, Calgary, AB

Alberta

Study Contact

Raneem Sheronick
Research Assistant
University of Calgary

Recruitment Start Date

January 15, 2022

Recruitment End Date

December 31, 2023
  • Learn more about observational studies
  • Learn more about clinical trials
  • Brain donations
  • More useful links and resources

Alzheimer Society of Canada logo

Alzheimer Society of Canada
20 Eglinton Avenue West, 16th Floor
Toronto, Ontario M4R 1K8
Information and Referral Line: 1-855-705-4636
Email: [email protected]

Charity registration number: 11878 4925 RR0001

Follow us:

  • Find us on Facebook
  • Follow us on Twitter
  • Follow us on Instagram
  • Subscribe to us on YouTube
  • Find us in LinkedIn

©2022 Alzheimer Society of Canada. All rights reserved.